PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. - Wikidata - wikimedia - TriplyDB

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein.

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein.

http://www.wikidata.org/entity/Q42826174

about

A comprehensive review on metabolic syndrome Adiponectin lowers glucose production by increasing SOGA Adipolin/C1qdc2/CTRP12 protein functions as an adipokine that improves glucose metabolism Inflammatory peptides derived from adipose tissue Association between lifestyle factors and plasma adiponectin levels in Japanese men.Adiponectin signaling and function in insulin target tissues The FGF21-adiponectin axis in controlling energy and vascular homeostasis Inflammation, oxidative stress and renin angiotensin system in atherosclerosis Beyond fat mass: exploring the role of adipokines in rheumatic diseases Hypoadiponectinaemia in diabetes mellitus type 2: molecular mechanisms and clinical significance Adiponectin and leptin molecular actions and clinical significance in breast cancer Role of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseases Adipocytokines and obesity-linked disorders The effects of exercise training on obesity-induced dysregulated expression of adipokines in white adipose tissue Adipokines in breast milk: an update Mifepristone promotes adiponectin production and improves insulin sensitivity in a mouse model of diet-induced-obesity Activation of PPARγ in myeloid cells promotes lung cancer progression and metastasis Possible involvement of Opa-interacting protein 5 in adipose proliferation and obesity Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent Obesity is associated with macrophage accumulation in adipose tissue Inside out: Bone marrow adipose tissue as a source of circulating adiponectin Identifying the links between obesity, insulin resistance and beta-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes 'Striking the Right Balance' in Targeting PPARgamma in the Metabolic Syndrome: Novel Insights from Human Genetic Studies Phytol/Phytanic acid and insulin resistance: potential role of phytanic acid proven by docking simulation and modulation of biochemical alterations Molecular, biochemical and functional characterizations of C1q/TNF family members: adipose-tissue-selective expression patterns, regulation by PPAR-gamma agonist, cysteine-mediated oligomerizations, combinatorial associations and metabolic functions A family of Acrp30/adiponectin structural and functional paralogs The eicosapentaenoic acid metabolite 15-deoxy-δ(12,14)-prostaglandin J3 increases adiponectin secretion by adipocytes partly via a PPARγ-dependent mechanism LPS-Enhanced Glucose-Stimulated Insulin Secretion Is Normalized by Resveratrol The peroxisome proliferator-activated receptor gamma agonist rosiglitazone ameliorates murine lupus by induction of adiponectin Activation of AMPK by berberine promotes adiponectin multimerization in 3T3-L1 adipocytes Potential role of marine algae extract on 3T3-L1 cell proliferation and differentiation: an in vitro approach CpG Methylation across the adipogenic PPARγ gene and its relationship with birthweight and child BMI at 9 years Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome Adipocytes as regulators of energy balance and glucose homeostasis The current role of thiazolidinediones in diabetes management.Adiponectin and cardiovascular disease: state of the art?The helix-loop-helix factors Id3 and E47 are novel regulators of adiponectin.Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin. Potential role in the modulation of its insulin-sensitizing activity.Inhibition of 11betaHSD1 with the S-phenylethylaminothiazolone BVT116429 increases adiponectin concentrations and improves glucose homeostasis in diabetic KKAy mice Anti-diabetic rosiglitazone remodels the adipocyte transcriptome by redistributing transcription to PPARγ-driven enhancers.

P2860

Q21284500-794B4431-3568-44C2-B41A-E3F275705C7C Q24298469-CC8A5A11-7951-4591-8730-B7C88A28B06A Q24635256-95CCBF54-F7C5-44AF-8CF0-695978E51B2D Q24800707-FDE5CD17-1EBA-49AF-B734-594A75718F6E Q24812059-2E121422-5377-4CC5-B4ED-A16E991FC907 Q26753354-2B8C448D-7C1F-415A-9D9D-E435D108A659 Q26753369-3BBC4329-0094-4C04-B115-26CE18D9EE69 Q26795756-E355E71D-3AD0-4DC1-8D10-549E18D11CE0 Q26864855-FB50E0DD-3699-4B25-B75E-BFBF70E9941D Q26865140-CBDCBD9E-785D-40CA-B973-6E91F0EEACE3 Q26998555-B5AF980B-4C29-4CBD-936B-5C2285261882 Q27008359-CA7A18E2-7E4B-4423-A614-58D14C268D0E Q27021977-BD0340DC-7AFD-474B-8A2E-94C3A7233DEC Q27024390-74AD4A78-31F0-4A34-B3A8-D29EC9C10A38 Q27026251-697F7E89-C8F6-4614-8A59-E404725AE865 Q27302419-4773EE74-B9C0-4AE8-AC8E-D3EF4654A56C Q27311601-B6A45768-0D4E-4242-99C0-59BE9F5EF7F0 Q27324265-0C5734CF-2075-4668-9DF9-3587AB7FFBBF Q27653305-8B9A0841-7C59-49CB-8FA5-C2CF999B496D Q27860976-B8FCF10D-9C08-4C21-B561-3F069B689CAA Q28073289-C5B7020E-E7A4-4983-BD59-D64C7A041458 Q28218908-4BE54BD3-889A-41AB-908F-5DC66A80037C Q28221639-7A8D61B6-BE70-419E-8A1A-BBC3725B9279 Q28484781-15529746-B53A-4015-BF3F-312EAA9E1572 Q28508387-06E9E6B9-B9EB-4E13-86E8-A77D4FE9F945 Q28513966-A763ECB5-6EE2-44EB-B5F2-0182F320AF9F Q28533399-95F8C3B4-8C7F-428A-B949-B5F1C284156A Q28552277-ECCDFBED-9658-4825-B799-A1B1CDA4B5D8 Q28585701-8ACF29BA-36E7-46C8-8610-D68F73ECC866 Q28592908-05226622-0297-4AD5-9B7D-5F9D2B671C8A Q28831150-F2F20A57-44DC-4628-9B82-694BD39C08EB Q29249078-13FA8CD7-47FC-43EB-9D74-378775511CEA Q29619211-308114CA-D4FF-4274-AC60-6B911ABE716D Q29619448-5887E819-8139-4A32-A675-C8B2A3551846 Q30250347-A65B81F2-160B-4A8A-A8F7-7E9AF7A473A7 Q30358456-30D08406-FDF4-4654-8F8A-0DFABD6F1DFB Q30438518-F9BC4392-A670-4B12-9AD0-BB6E05DCF38C Q31044833-094E7CFD-A2B9-46D5-B5E5-2EEA35442524 Q33319513-736E6D61-08DA-4E3F-8B80-9D3E6BB54F50 Q33600223-19261127-D2B1-4A74-A62E-7C267B85C38F

P2860

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein.

http://www.wikidata.org/entity/Q42826174

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

2001年论文

@zh

2001年论文

@zh-cn

name

PPARgamma ligands increase exp ...... n, an adipose-derived protein.

@en

PPARgamma ligands increase exp ...... n, an adipose-derived protein.

@nl

type

label

PPARgamma ligands increase exp ...... n, an adipose-derived protein.

@en

PPARgamma ligands increase exp ...... n, an adipose-derived protein.

@nl

prefLabel

PPARgamma ligands increase exp ...... n, an adipose-derived protein.

@en

PPARgamma ligands increase exp ...... n, an adipose-derived protein.

@nl

P1433

Q42826174-BB37685F-A3E9-4A2C-BE9F-991F8A707E95

P1476

Q42826174-B29E13C9-B080-4626-B909-7D0E7E033660

P2093

Q42826174-03709D7B-8046-43E3-98F3-C1D7D4EBF534

Q42826174-066A16D2-FA86-4A23-8F7A-89C99019013B

Q42826174-264C1370-A94B-43E7-B0F3-8F343120B290

Q42826174-36BC96AC-C271-483C-B0C8-40C935B94E17

Q42826174-51C64A68-1C47-48D2-8A78-83FBA534A3CA

Q42826174-56FB6BA7-9BED-481F-831E-23EFC1A75122

Q42826174-58D36B28-E8A0-45DD-991D-435D8D78211E

Q42826174-8153B43A-C155-4B2A-A9F7-7E5E8C00CE6B

Q42826174-B06FEBE6-8030-4CC2-97D2-E2C609106BA2

Q42826174-C98A96DA-D7F8-4DAA-8E31-ED37CFA83384

P304

Q42826174-FDE01ACB-AC54-442F-9122-8546FC878B75

P31

Q42826174-12C7C063-B100-4790-8104-EE929EC1B0FC

P356

Q42826174-942C8E59-D0DB-4944-BFF4-4601B113FE25

P407

Q42826174-E79BB3EA-1DBE-4AFB-AB84-180343A34D1D

P433

Q42826174-F9A5509D-5066-478E-8CC5-FEDF38F92B58

P478

Q42826174-09B9F432-290F-42C0-9BC3-781C1C8BCA89

P577

Q42826174-DB3FD22B-AEE2-41ED-9381-A81FD2FA6A93

P5875

Q42826174-8FB4089C-F33F-4714-8DF1-97D9A11AE700

P698

Q42826174-D84F970A-BC4B-468C-A350-79460254A4F5

P356

DIABETES.50.9.2094

P1433

P1476

PPARgamma ligands increase exp ...... n, an adipose-derived protein.

@en

P2093

H Kuriyama

http://www.w3.org/2001/XMLSchema#string

H Nagaretani

http://www.w3.org/2001/XMLSchema#string

H Nishizawa

http://www.w3.org/2001/XMLSchema#string

I Shimomura

http://www.w3.org/2001/XMLSchema#string

K Hotta

http://www.w3.org/2001/XMLSchema#string

K Kishida

http://www.w3.org/2001/XMLSchema#string

M Matsuda

http://www.w3.org/2001/XMLSchema#string

M Takahashi

http://www.w3.org/2001/XMLSchema#string

N Maeda

http://www.w3.org/2001/XMLSchema#string

N Ouchi

http://www.w3.org/2001/XMLSchema#string

P304

2094-2099

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DIABETES.50.9.2094

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P577

2001-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

239987374

http://www.w3.org/2001/XMLSchema#string

P698

11522676

http://www.w3.org/2001/XMLSchema#string